Clinical Trials Directory

Trials / Completed

CompletedNCT02549976

Evaluation of Digestive Damage and Associated Predictive Factors in Crohn's Disease 5 to 10 Years After Diagnosis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
54 (actual)
Sponsor
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary objective is to evaluate digestive damage in CD 5 to 10 years after diagnosis in the GETAID centers included in the RAPID study. Secondary objective is to identify predictive factors of the evolution digestive damage.

Detailed description

Background: Crohn's disease (CD) is a chronic inflammatory disorder of the bowel that is characterized by periods of clinical remission alternating with periods of recurrence. Persistent inflammation is believed to lead to progressive bowel damage that, over time, will manifest in the development of strictures, fistulae, and abscesses. The recent development of the Lemann index allows us to precisely assess digestive damage in CD. The aim of the present study is to evaluate digestive damage and associated predictive factors in CD 5 to 10 years after diagnosis. Methods: Prospective, multicenter, international, transversal, observational study. Patients who completed the RAPID trial (evaluating the benefits on the course of CD of an early prescription of azathioprine compared with conventional step-care therapy) will be eligible. Digestive damage will be assessed using methods described in the Lemann index protocol, dependent on CD location (abdominal MRI obligatory). The total duration of study participation for 1patient will be ≤4 months. Aims: The primary objective is to evaluate digestive damage in CD 5 to 10 years after diagnosis in the GETAID centers included in the RAPID study. Secondary objective is to identify predictive factors of the evolution digestive damage.

Conditions

Interventions

TypeNameDescription
PROCEDUREAbdominal MRIAbdominal MRI to realize within 4 months following inclusion
PROCEDUREUpper endoscopyUpper endoscopy to realize within 4 months following inclusion
PROCEDUREColonoscopyColonoscopy to realize within 4 months following inclusion
PROCEDUREPelvic MRIPelvic MRI to realize within 4 months following inclusion

Timeline

Start date
2015-12-01
Primary completion
2018-02-01
Completion
2018-02-01
First posted
2015-09-15
Last updated
2018-07-31

Locations

9 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02549976. Inclusion in this directory is not an endorsement.